Effects of the NMDA receptor antagonist MK-801 on short-interval timing in rats

Behavioral Neuroscience

Volumn 120, Issue 1, 2006, Pages 162-172

  Miller, Jonathan P ^a   McAuley, J Devin ^a   Pang, Kevin C H ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

Fisher 344; Peak interval procedure; Temporal processing

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; MALE; NONHUMAN; RAT; STATISTICAL ANALYSIS; TIME; TRAINING;

ANIMALS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, INBRED F344; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 33644755856     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.120.1.162     Document Type: Article

References (58)

1. Beninger, R. J., & Hahn, B. L. (1983, June 17). Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science, 220, 1304-1306.
2. Berz, S., Battig, K., & Welzl, H. (1992). Effects of CGS-19755 and dizocilpine (MK-801) on delayed time discrimination performance. Behavioural Brain Research, 51, 185-192.
3. Buhusi, C. V., & Meck, W. H. (2000). Timing for the absence of a stimulus: The gap paradigm reversed. Journal of Experimental Psychology: Animal Behavior Processes, 26, 305-322.
4. Buhusi, C. V., Mocanu, M., & Meck, W. H. (2004). Abnormal memory consolidation of interval timing in rats with ibotenic lesions of the hippocampus (Program no. 550.18.2004 Abstract Viewer/itinerary planner). Washington, DC: Society for Neuroscience.
5. Buhusi, C. V., Perera, D., & Meck, W. H. (2005). Memory for timing visual and auditory signals in albino and pigmented rats. Journal of Experimental Psychology: Animal Behavior Processes, 31, 18-30.
6. Buhusi, C. V., Sasaki, A., & Meck, W. H. (2002). Temporal integration as a function of signal and gap intensity in rats (Rattus norvegicus) and pigeons (Columba livia). Journal of Comparative Psychology, 116, 381-390.
7. Butterfield, D. A., & Pocernich, C. B. (2003). The glutamatergic system and Alzheimer's disease: Therapeutic implications. CNS Drugs, 17, 641-652.
8. Cabeza de Vaca, S., Brown, B. L., & Hemmes, N. S. (1994). Internal clock and memory processes in animal timing. Journal of Experimental Psychology: Animal Behavior Processes, 20, 184-198.
9. Castellano, C., Cestari, V., Ciamei, A., & Pavone, F. (1999). MK-801-induced disruptions of one-trial inhibitory avoidance are potentiated by stress and reversed by naltrexone. Neurobiology of Learning and Memory, 72, 215-229.
10. Castellano, C., Pavone, F., & Allegra, S. P. (1984). Morphine and memory in Dba/2 mice: Effects of stress and of prior experience. Behavioural Brain Research, 11, 3-10.
11. Cestari, V., & Castellano, C. (1997). MK-801 potentiates morphine-induced impairment of memory consolidation in mice: Involvement of dopaminergic mechanisms. Psychopharmacology, 133, 1-6.
12. Church, R. M. (2003). A concise introduction to scalar timing theory. In W. H. Meck (Ed.), Functional and neural mechanisms of interval timing (pp. 3-22). Boca Raton, FL: CRC Press.
13. Cotman, C. W., Monaghan, D. T., Ottersen, O. P., & Storm-Mathisen, J. (1987). Anatomical organization of excitatory amino-acid receptors and their pathways. Trends in Neurosciences, 10, 273-280.
14. Ford, L. M., Sanberg, P. R., Norman, A. B., & Fogelson, M. H. (1989). MK-801 prevents hippocampal neurodegeneration in neonatal hypoxicischemic rats. Archives of Neurology, 46, 1090-1096.
15. Gibbon, J. (1977). Scalar expectancy theory and Weber's law in animal timing. Psychological Review, 84, 279-325.
16. Gibbon, J., Church, R. M., & Meck, W. H. (1984). Scalar timing in memory. Annals of the New York Academy of Sciences, 423, 52-77.
17. Hinton, S. C., & Meck, W. H. (1997). How time flies: Functional and neural mechanisms of interval timing. In C. M. Bradshaw & E. Szabadi (Eds.), Time and behaviour: Psychological and neurobehavioural analyses (Vol. 120, pp. 409-458). Amsterdam, the Netherlands: Elsevier.
18. Jarrard, L. E. (1973). The hippocampus and motivation. Psychological Bulletin, 79, 1-12.
19. Jeziorski, M., White, F. J., & Wolf, M. E. (1994). MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse, 16, 137-147.
20. Kramer, T. J., & Rilling, M. (1970). Differential reinforcement of low rates: A selective critique. Psychological Bulletin, 74, 225-254.
21. Kumar, S. (2004). Memantine: Pharmacological properties and clinical uses. Neurology India, 52, 307-309.
22. Manahan-Vaughan, D., & Braunewell, K. H. (2005). The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cerebral Cortex, 15, 1703-1713.
23. Marek, P., Beneliyahu, S., Gold, M., & Liebeskind, J. C. (1991). Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Research, 547, 77-81.
24. Maricq, A. V., & Church, R. M. (1983). The differential effects of haloperidol and methamphetamine on time estimation in the rat. Psychopharmacology, 79, 10-15.
25. Maricq, A. V., Roberts, S., & Church, R. M. (1981). Methamphetamine and time estimation. Journal of Experimental Psychology: Animal Behavior Processes, 7, 18-30.
26. Matell, M. S., King, G. R., & Meck, W. H. (2004). Differential modulation of clock speed by the administration of intermittent versus continuous cocaine. Behavioral Neuroscience, 118, 150-156.
27. Meck, W. H. (1983). Selective adjustment of the speed of internal clock and memory processes. Journal of Experimental Psychology: Animal Behavior Processes, 9, 171-201.
28. Meck, W. H. (1986). Affinity for the dopamine D2 receptor predicts neuroleptic potency in decreasing the speed of an internal clock. Pharmacology, Biochemistry, and Behavior, 25, 1185-1189.
29. Meck, W. H. (1988). Hippocampal function is required for feedback control of an internal clock's criterion. Behavioral Neuroscience, 102, 54-60.
30. Meck, W. H. (1994). Cholinergic function and the internal clock. Behavioural Pharmacology, 5, 27.
31. Meck, W. H. (1996). Neuropharmacology of timing and time perception. Brain Research: Cognitive Brain Research, 3(3-4), 227-242.
32. Meck, W. H., & Church, R. M. (1987). Nutrients that modify the speed of internal clock and memory storage processes. Behavioral Neuroscience, 101, 465-475.
33. Meck, W. H., Church, R. M., & Olton, D. S. (1984). Hippocampus, time, and memory. Behavioral Neuroscience, 98, 3-22.
34. Meck, W. H., Church, R. M., Wenk, G. L., & Olton, D. S. (1987). Nucleus basalis magnocellularis and medial septal area lesions differentially impair temporal memory. Journal of Neuroscience, 7, 3505-3511.
35. Minkeviciene, R., Banerjee, P., & Tanila, H. (2004). Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. Journal of Pharmacology and Experimental Therapeutics, 311, 677-682.
36. Monaghan, D. T., & Cotman, C. W. (1985). Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. Journal of Neuroscience, 5, 2909-2919.
37. Morris, R. G. M. (2003). Long-term potentiation and memory. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 358, 643-647.
38. Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986, February 27-March 5). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature, 319, 774-776.
39. Ohyama, T., Horvitz, J. C., Drew, M. R., Gibbon, J., Malapani, C., & Balsam, P. D. (2000). Conditioned and unconditioned behavioral-cognitive effects of a dopamine antagonist in rats. Behavioral Neuroscience, 114, 1251-1255.
40. Olton, D. S. (1989). Frontal cortex, timing and memory. Neuropsychologia, 27, 121-130.
41. Olton, D. S., Wenk, G. L., Church, R. M., & Meck, W. H. (1988). Attention and the frontal cortex as examined by simultaneous temporal processing. Neuropsychologia, 26, 307-318.
42. Quevedo, J., Moretto, A., Colvero, M., Roesler, R., & Ferreira, M. B. C. (1997). The N-methyl-D-aspartate receptor blocker MK-801 prevents the facilitatory effects of naloxone and epinephrine on retention of inhibitory avoidance task in rats. Behavioural Pharmacology, 8, 471-474.
43. Roberts, S. (1981). Isolation of an internal clock. Journal of Experimental Psychology: Animal Behavior Processes, 7, 242-268.
44. Rogawski, M. A., & Wenk, G. L. (2003). The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Reviews, 9, 275-308.
45. Sanger, D. J. (1992). NMDA antagonists disrupt timing behaviour in rats. Behavioural Pharmacology, 3, 593-600.
46. Sanger, D. J., & Jackson, A. (1989). Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats. Journal of Pharmacology and Experimental Therapeutics, 248, 1215-1221.
47. Shapiro, M. L., & Caramanos, Z. (1990). NMDA antagonist MK-801 impairs acquisition but not performance of spatial working and reference memory. Psychobiology, 18, 231-243.
48. Shapiro, M. L., & O'Connor, C. (1992). N-methyl-D-aspartate receptor antagonist MK-801 and spatial memory representation: Working memory is impaired in an unfamiliar environment but not in a familiar environment. Behavioral Neuroscience, 106, 604-612.
49. Siegel, S. (1988). State dependent learning and morphine tolerance. Behavioral Neuroscience, 102, 228-232.
50. Stephens, D. N., & Cole, B. J. (1996). AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology, 126, 249-259.
51. Tonkiss, J., Morris, R. G., & Rawlins, J. N. (1988). Intra-ventricular infusion of the NMDA antagonist AP5 impairs performance on a non-spatial operant DRL task in the rat. Experimental Brain Research, 73, 181-188.
52. Tracy, A. L., Jarrard, L. E., & Davidson, T. L. (2001). The hippocampus and motivation revisited: Appetite and activity. Behavioural Brain Research, 127, 13-23.
53. Trujillo, K. A., & Akil, H. (1994). Inhibition of opiate tolerance by noncompetitive N-methyl-D-aspartate receptor antagonists. Brain Research, 633, 178-188.
54. Watkins, J. C., Krogsgaard-Larsen, P., & Honore, T. (1990). Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends in Pharmacological Sciences, 11, 25-33.
55. Welzl, H., Berz, S., & Battig, K. (1991). The effects of the noncompetitive NMDA receptor antagonist MK 801 on DRL performance in rats. Psychobiology, 19, 211-216.
56. Whishaw, I. Q., & Auer, R. N. (1989). Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology, 98, 500-507.
57. Wong, E. H., Kemp, J. A., Priestley, T., Knight, A. R., Woodruff, G. N., & Iversen, L. L. (1986). The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proceedings of the National Academy of Sciences, USA, 83, 7104-7108.
58. Zeiler, M. (1977). Schedules of reinforcement: The controlling variables. In W. K. Honig & J. E. R. Staddon (Eds.), Handbook of operant behavior (pp. 201-232). Englewood Cliffs, NJ: Prentice Hall.